Dennis Kim

41PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)HaematologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jun 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.

|Apr 23, 2026
ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors.

|Oct 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.

Sergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux

|Sep 18, 2025
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis.

Ruah Alyamany, Ahmed Alnughmush, Mats Remberger

|Sep 14, 2025
Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment.

Sergio Rodriguez-Rodriguez, Nihar Desai, Carol Chen

|Aug 27, 2025
A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation.

Nihar Desai, Sergio Rodriguez-Rodriguez, Eshrak Al-Shaibani

Pageof 7

Frequent Collaborators

22 joint publications

Fotios V Michelis

18 joint publications

Arjun Law

16 joint publications

Rajat Kumar

15 joint publications

Ivan Pasic